This invention provides antibodies that interact with or bind to human interferon-gamma (IFN-.gamma.) and methods for treating IFN-.gamma. mediated diseases by administering a pharmaceutically effective amount of antibodies to IFN-.gamma.. Methods of detecting the amount of IFN-.gamma. in a sample using antibodies to IFN-.gamma. are also provided.